Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0422) | |||||
|---|---|---|---|---|---|
| DME Name | Estradiol 17-beta-dehydrogenase 2 (HSD17B2), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 1.1.1.62 (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification Healthy | |||||
| ICD-11: Healthy | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
| Transcription-factor regulation | |||||
| Transcription factor Sp1 (SP1) | Health | Activation | |||
| Uniprot ID | |||||
| Interaction Name | SP1-HSD17B2 interaction | [1], [2] | |||
| Studied Cell Lines | Human endometrial epithelial cell line | ||||
| Ensembl ID | |||||
| Description | Transcription factor Sp1 (SP1) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP1 and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
| Transcription factor Sp3 (SP3) | Health | Activation | |||
| Uniprot ID | |||||
| Interaction Name | SP3-HSD17B2 interaction | [1], [2] | |||
| Studied Cell Lines | Human endometrial epithelial cell line | ||||
| Ensembl ID | |||||
| Description | Transcription factor Sp3 (SP3) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP3 and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Multilayered rosettes embryonal tumour | Moderate hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 2.75E-07; delta-beta: -2.63E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HSD17B2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Lymphoma | Moderate hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 1.60E-06; delta-beta: -2.55E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HSD17B2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2B5F Uterine carcinosarcoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Uterine carcinosarcoma | Significant hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.15E-02; delta-beta: -3.24E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2B71 Gastric cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Gastric cancer | Significant hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Adjacent Tissue | Significant hypomethylation p-value: 1.74E-02; delta-beta: -4.25E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2B90 Colorectal cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Colorectal cancer | Moderate hypermethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypermethylation p-value: 1.78E-03; delta-beta: 2.27E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the HSD17B2 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2C76 Endometrial cancer | Click to Show/Hide the Full List of HOSPPI: 4 HOSPPI | ||||
| Transcription-factor regulation | |||||
| Retinoic acid receptor alpha (RARA) | Endometrial cancer | Activation | |||
| Uniprot ID | |||||
| Interaction Name | RARA-HSD17B2 interaction | [1] | |||
| Studied Cell Lines | Ishikawa and RL95-2 cell lines | ||||
| Ensembl ID | |||||
| Description | Retinoic acid receptor alpha (RARA) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between RARA and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
| Retinoid X receptor alpha (RXRA) | Endometrial cancer | Activation | |||
| Uniprot ID | |||||
| Interaction Name | RXRA-HSD17B2 interaction | [1] | |||
| Studied Cell Lines | Ishikawa and RL95-2 cell lines | ||||
| Ensembl ID | |||||
| Description | Retinoid X receptor alpha (RXRA) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between RXRA and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
| Transcription factor Sp1 (SP1) | Endometrial cancer | Repression | |||
| Uniprot ID | |||||
| Interaction Name | SP1-HSD17B2 interaction | [1] | |||
| Studied Cell Lines | Ishikawa and RL95-2 cell lines | ||||
| Ensembl ID | |||||
| Description | Transcription factor Sp1 (SP1) is reported to repress the transcription of HSD17B2 gene, which leads to a decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP1 and HSD17B2 can repress the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
| Transcription factor Sp2 (SP2) | Endometrial cancer | Repression | |||
| Uniprot ID | |||||
| Interaction Name | SP2-HSD17B2 interaction | [1] | |||
| Studied Cell Lines | Ishikawa and RL95-2 cell lines | ||||
| Ensembl ID | |||||
| Description | Transcription factor Sp2 (SP2) is reported to repress the transcription of HSD17B2 gene, which leads to a decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP2 and HSD17B2 can repress the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
| ICD-11: 2C82 Prostate cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Prostate cancer | Moderate hypermethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypermethylation p-value: 9.79E-04; delta-beta: 2.42E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the HSD17B2 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2F9A Endocrine gland cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Craniopharyngioma | Significant hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 3.15E-05; delta-beta: -3.20E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
| ICD-11: 5A61 Pituitary gland hypofunction | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Chordoma | Significant hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 6.13E-05; delta-beta: -4.08E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 5B81 Obesity | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Obesity | Moderate hypomethylation | |||
| Interaction Name | DNMT-HSD17B2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 1.62E-12; delta-beta: -2.24E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HSD17B2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

